Clinical Trial Update: Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating the efficacy of MK0557 in combination with sibutramine or orlistat for obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MK0557
• Orlistat (orlistat)
• Sibutramine (sibutramine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED